Biodelivery Sciences International reported $25.78M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.69M 1.05M
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Agile Therapeutics AGRX:US $ 15.83M 2.76M
Alimera Sciences ALIM:US $ 8.69M 456K
Antares Pharma ATRS:US $ 17.7M 97K
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biodelivery Sciences International BDSI:US $ 25.78M 1.98M
Cara Therapeutics CARA:US $ 5.65M 683K
Cti Biopharma CTIC:US $ 10.21M 2.59M
Daiichi Sankyo 4568:JP 79.12B 24.69B
Depomed DEPO:US $ 26.24M 18.5M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
JAZZ PHA JAZZ:US 429.03M 168.52M
Johnson & Johnson JNJ:US $ 6B 73M
Knight Therapeutics Inc GUD:CN C$ 18.63M 3.94M
Lannett LCI:US $ 21.58M 3.94M
Mannkind MNKD:US $ 20.06M 2.64M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Pfizer PFE:US $ 2.79B 134M
Redhill Biopharma RDHL:US 25.47M 4.48M
Revance Therapeutics RVNC:US $ 49.01M 937K
Teva Pharmaceutical TEVA:IT 832M 16M